ECRIN - European Clinical Research Infrastructure Network

Funding Calls

This list of calls for funding for COVID19 is curated by ECRIN and updated on a monthly basis. Calls featured in this list focus on research opportunities for European investigators, mainly in the field of clinical research, or areas underpinning clinical research. Last update on 07-11-2020.



KCE Clinical trials on COVID-19 NA 15-04-2021

Czech Republic
Czech Technology Agency Innovative solutions for combating the current epidemic and improving preparedness in future outbreaks 40 M CZK per project 31-12-2020

Federal Ministry of Education and Research Vaccine development and clinical trials NA 31-12-2020

Volkswagen Foundation Basic research and first phases of clinical research for new drugs against COVID-19 and emerging viral diseases 700K €/project 10-12-2020

Malta Council for Science and Technology & Malta Enterprise Epidemiology, Basic Science, Clinical Research, Social Sciences, IT, 5,3 M € total 30-12-2020

NHS Scotland Innovative solutions that can support the NHS Scotland in its fight against COVID-19 £25K Rolling applications 

Banco Santander/Crue Universidades Espanolas Big data analysis, clinical research, basic science, socio-economic impact, innovative products and solutions for crisis mitigation 8,5 M € Total Rolling applications until 18 December 2020

Swedish Research Council Exceptional redirection of ongoing grants to focus on COVID19 No more than 1/3 of amount yearly allocate Ongoing – requires an authorization

United Kingdom
British Heart Foundation Clinical research on cardiovascular disease and COVID19 Not specified – applications must align with UK COVID19 priorisation process Rolling applications evaluated weekly

United Kingdom
Foundation for a smoke-free world Preclinical, clinical and epidemiological research at the intersection of smoking and COVID-19 US$ 500K 15 -12- 020

United Kingdom
UK MRC Virology, Immunity and Pathophysiology, Diagnostics, Epidemiology, PPE and other protective material, Public Health, Clinical Research, Vaccines, Health Care and Delivery Variable depending on project needs Rolling call - 1 Apr 2021

United Kingdom
NIHR Which drug or antibody interventions are effective, cost-effective, safe and most acceptable for prophylaxis of COVID-19 in a UK care home setting? NA 11-11-2020

United Kingdom
NIHR Urgent Public Health Research – through National Priorisation Process NA Rolling applications

United Kingdom
UK Research and Innovation Innovative solutions to gather critical data, support manufacture or wide scale adoption of an intervention, better understand and mitigate impact of the epidemic 80% of the full economic cost none - apply at any time

Pan European
Partnership for Advanced Computing in Europe (PRACE) Projects requesting computer resources for: epidemiology, bioinformatics, bio-simulation, biomolecular analysis, other studies to mitigate the epidemic Resources requested reviewed for each proposal Open until further notice


Legal disclaimer for the COVID-19 Taksforce internet pages.